Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C6H12O3
CAS Number:
Molecular Weight:
132.16
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
204-639-8
Beilstein/REAXYS Number:
80142
MDL number:
Assay:
≥97.0% (GC)
Form:
liquid
InChI
1S/C6H12O3/c1-4-7-5(2)9-6(3)8-4/h4-6H,1-3H3
InChI key
SQYNKIJPMDEDEG-UHFFFAOYSA-N
SMILES string
CC1OC(C)OC(C)O1
assay
≥97.0% (GC)
form
liquid
drug control
USDEA Schedule IV
refractive index
n20/D 1.405
bp
123-124 °C
density
0.994 g/mL at 20 °C (lit.)
functional group
ether
Quality Level
Looking for similar products? Visit Product Comparison Guide
Application
Reactant involved in:
- Modified Sanford reaction
- Synthesis of N-arylbenzoquinaldinium derivatives with antimicrobial activity
- Hydroformylation of alkenylamines
- Studies of molecules with inhibitory activity against HIV-1 integrase
- Irregular Wittig reactions for the formation of α-hydroxyketones
Other Notes
Sales restrictions may apply
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
Storage Class
3 - Flammable liquids
wgk
WGK 1
flash_point_f
75.2 °F - closed cup
flash_point_c
24 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Regulatory Information
危险化学品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
R E Garr et al.
Developmental medicine and child neurology, 41(1), 44-47 (1999-03-06)
All children who presented in a convulsion, including convulsive status epilepticus, to the accident and emergency department over a 12-month period and who required treatment, were reviewed retrospectively to identify the effectiveness and safety of a specific treatment protocol. This
Type of syringe for giving paraldehyde injection.
C R Dass
Indian pediatrics, 37(4), 448-448 (2000-04-26)
D L Armstrong et al.
Journal of child neurology, 16(12), 915-917 (2002-01-12)
Seizures are commonly associated with hypoxic-ischemic encephalopathy. Although the majority of cases are controlled with first- or second-line therapy, others develop pervasive seizures, requiring multiple anticonvulsants. To provide data on the incidence of seizures and response to anticonvulsant therapies, a
P Carpentier et al.
Fundamental & clinical pharmacology, 6(7), 309-318 (1992-01-01)
The ability of paraldehyde, a potent central nervous system depressant, to prevent the convulsions induced by the organophosphate soman, an irreversible inhibitor of acetylcholinesterase, was studied in rats. Paraldehyde (0.1-500 mg/kg, im) administered 10 min before soman (100 micrograms/kg, sc)
Pharmacological management of convulsive status epilepticus in children.
R C Scott et al.
Developmental medicine and child neurology, 41(3), 207-210 (1999-04-21)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service